This discussion focuses on the dynamic nature of three chronic congenital infections of man, namely those caused by cytomegaloviruses, rubella virus, and Toxoplasma gondii. The spectra of the fetal infection are described and the risks associated with the acute and chronic phases of the fetal infections are contrasted. Because of their frequency and subtlety, emphasis is placed on the late-appearing sequelae which are associated with the persistent and/or recurring aspects of these infections.
The risks of congenitally acquired infections will be discussed here in terms of the nature of disease in the fetus, infant, and child caused by cytomegaloviruses (CMV), rubella virus, and Toxoplasma gondii. Although these organisms have relatively low pathogenicity, even for the human conceptus, they can produce acute, multi-organ system disease in the fetus. More commonly, however, the intrauterine infection is subclinical but with a variable tendency to produce subtle, late-appearing defects in association with persistent and/or recurring infections long after delivery. Because of their frequency, the subclinical infections are equally as important from a public health standpoint as the clinically apparent ones. CYTOMEGALOVIRUS CMV is the most common cause of intrauterine infection in man, occurring in one percent (0.5-2.3 percent) of all live births throughout the world [1, 2] . It is more prevalent in lower socioeconomic sectors of developed nations and in developing countries. About five percent of the infected infants have typical cytomegalic inclusion disease, another five percent may have atypical clinical involvement, and 90 percent are born with subclinical infection [2] . Irrespective of the nature of the infection, CMV is usually excreted for months from the nasopharnyx and for years into the urine following in utero involvement [3] . The more severe types of this infection are associated with increased antigenic stimulation in the form of higher levels of virus production in the early months following delivery and increased immunologic stimulation, as measured by accelerated immunoglobulin development (especially IgM) with higher levels of antibody and immune complex formation [3, 4] .
Although there may be infection of multiple organs, cytomegalic inclusion disease of the newborn is typically characterized by involvement of the reticulo-endothelial and central nervous systems [5, 6] . Clinically, some combination of petechiae, hepatosplenomegaly, and jaundice are seen in all of the infected patients. In addition, a significant prenatal insult is indicated by the occurrence of microcephaly, intrauterine growth retardation, and prematurity in approximately 50 percent of cases. These latter defects seldom occur as isolated ones. From the laboratory standpoint, the following are found in decreasing order of frequency: increased cord serum IgM (> 20 mg/100 ml), atypical lymphocytosis (> 5 percent), elevated SGOT (> 80 uU/ml), thrombocytopenia (< 100,000 platelet/cu mm), conjugated hyperbilirubinemia (indirect serum bilirubin > 2 mg/100 ml) and increased cerebrospinal fluid protein (> 120 mg/100 ml). These laboratory abnormalities are found in from 50-90 percent of the cases. Mortality rates can range as high as 30 percent with severe typical disease in the young infant [5] or the fetal infection may be fulminant with obvious multiple organ system involvement at birth or may have run its course in utero and present as isolated central nervous system involvement, such as microcephaly without other findings. At the other end of the spectrum, the fetal infection may have minimal manifestations that are easily overlooked or misdiagnosed in early infancy, but which still result in significant central nervous system damage in later life. With cytomegalic inclusion disease, the outlook for normal development is bleak since upward of 90 percent of infected infants will develop significant mental and/or perceptual defects in the first two years after delivery [5, 6] . Microcephaly, usually coupled with severe intellectual deficits and/or neuromuscular disorders (seizures, paresis, and spasticity), is observed in 80 percent or more of the cases. In addition, severe hearing loss and ocular abnormalities (chorioretinitis and optic atrophy) occur in 25 to 30 percent, often in association with the central nervous system defects.
In infants with subclinical infection, the outlook is much better. Nevertheless, about ten percent of these infants will develop severe degrees of deafness which can appear de novo in later life, usually within the first two years, and which may be progressive [7] . In as yet an undetermined number, the subclinical infection may be associated with the later development of minimal brain dysfunction syndromes, manifested as intellectual deficits and behavioral disorders [8] . Recently, we have observed striking dental defects, simiilar to those seen with congenital rubella, in association with congenital CMV infection.
Conservatively estimating a one percent incidence for congenital CMV infection and three million live births per year in the U.S.A., about 3000 infants will become severely handicapped annually as a result of typical or atypical cytomegalic inclusion disease [2] . Another 3000 or more will develop significant hearing and mental deficits as a result of the subclinical infection. Hence, as emphasized by Weller, the year-in-and-year-out toll of handicaps resulting from endemic CMV infection far exceeds that produced by rubella virus, where the major impact is more dramatic but limited to epidemic cycles [1] .
The reason for the high incidence of congenital CMV infection compared to other chronic intrauterine infection is that the virus can be transmitted in utero not only with primary maternal infection but also in the course of recurrent maternal infection resulting from reactivation of latent virus in immune women [2, 9] . With the other infections, intrauterine involvement occurs almost exclusively with primary maternal infection. Recent data indicate, however, that primary maternal CMV infection is associated with the more virulent form of fetal infection [10] . Whether recurrent maternal infection can result in subtle infection with late-appearing se- quelae is yet to be determined, but is an important consideration with respect to use of live vaccines for the control of congenital CMV infection. RUBELLA Unlike CMV, congenital rubella is believed to occur only with primary maternal infection when virus in the circulation can infect the placenta and subsequently seed the fetus [11] . Although reinfection can occur in a small percentage of cases following natural infection and a higher percentage following vaccination [12] , maternal immunity is thought to protect against in utero transmission of virus.
There are no really good estimates for the incidence of congenital rubella for many reasons. Rubella is often subclinical in the mother and baby, may mimic other infections in the mother, and occurs in epidemic waves which are variable as regards their occurrence, size, and virulence [11] . In the U.S.A., widespread vaccination of children, the major purveyors of rubella in the past, has altered the pattern of epidemicity favorably, but has resulted in women of childbearing ages becoming the main target for infection in recent years [13] . Widespread epidemics still occur in most other areas of the world where the vaccination programs are focused on females in the childbearing years. Under these circumstances, congenital rubella remains a major problem. In the U.S.A., rubella remains a significant problem since women in the childbearing ages remain susceptible, as they were too old to be immunized when the vaccine was first introduced.
The fetal infection is persistent with viral excretion (nasopharynx, urine, conjunctive) commonly demonstrable for the first few months after delivery, but with diminishing frequency thereafter. During gestation only a few or many fetal organs can become infected. Consequently, congenital rubella results in a wide spectrum of disease in the young infant, favoring subclinical involvement in the early months of life [1 1,14] . Since rubella virus can infect the fetus in the earliest stages of gestation it classically results in disturbances of embryogenesis. However, continuing viral replication can cause chronic damage in later gestation and well into the postnatal period, likely through vascular insufficiency and subtle cytopathology rather than inflammatory damage, which is more characteristic of the other chronic congenital infections [11] .
Even among newborns with clinically evident congenital rubella, the range of disease is broad [11, 15] . Although there may be gross anatomical defects in many organ systems, they are relatively rare except for the cardiovascular abnormalities with characteristic disturbances of the pulmonary arterial system, the ductus, and the aortic isthmus. Other common defects which probably result from chronic infection include: intra-and extrauterine growth retardation, hepatosplenomegaly, thrombocytopenia with purpura, adenopathy, active encephalitis, retinopathy, deafness, interstitial pneumonia, cataracts, and bony radiolucencies. Cardiac defects with early heart failure, rapidly progressive hepatitis, extensive meningoencephalitis, fulminant interstial pneumonia, and major anatomical defects carry a poor prognosis for survival. Many of the defects are masked during the neonatal period only to become progressive in the ensuing months. Cardiac defects, pneumonia, hepatitis, encephalitis, and eye defects are in this category. Although 70 percent of young infants with congenital rubella may be subclinically infected, evident disease including most commonly isolated hearing defects will develop in 70 percent or more of them within the first five years after delivery [14] .
Certain sequelae of congenital rubella may not appear until many years after delivery [11] . Deafness, the most common defect of congenital rubella, is easily missed in young infants. However, it may appear de novo in later childhood and can even be progressive like that seen following congenital CMV infection. Language, learning, and psychiatric disorders resulting from the central nervous system involvement may also be quite delayed in onset. Late-appearing endocrine abnormalities include diabetes mellitus and, rarely, thyroid dysfunction, growth hormone disturbances, and precocious puberty. Visual and dental abnormalities frequently appear late. In addition, active infection of the central nervous system may recur in late childhood, manifesting itself as a subacute progressive panencephalitis. Exactly how rubella, an RNA virus, persists in the human host long after viral excretion disappears is a moot point but an intriguing one for future research. Gestational age at the time of the maternal infection is the most important factor influencing intrauterine transmission and virulence of the fetal infection. At least during the first half of gestation the rate of fetal infections and its virulence are inversely related to gestational age [11] . The infection is more common and severe when acquired in the first ten weeks of gestation than when acquired later. Recent data, however, indicate that rubella virus may be transmitted in utero in late gestation much more frequently than previously thought [16] . Whether there is a pathologic potential associated with late gestational transmission is unknown. Significant disease is apparently not a problem with natal and early postnatal transmission. TOXOPLASMOSIS Congenital toxoplasmosis, rather than being caused by a virus, results from fetal infection by the protozoan parasite, Toxoplasma gondii [17] . The only natural hosts for this organism are members of the feline family. All other animals, including man, are secondary hosts who experience end-stage infection by trophozoites with the formation of infectious pseudocysts in muscle and certain viscera which remain infectious for many years. Pregnant women, then, are infected upon consumption of undercooked fresh meat or upon exposure to infectious oocytes excreted by infected cats, usually acutely infected kittens. In the U.S.A., the incidence of congenital toxoplasmosis varies from one per 1000 to 3000 live births. It is much more prevalent in Europe due to a greater consumption of rare meat and in areas where there are large populations of cats and poor sanitation. Infection of the product of conception results from primary, usually subclinical, maternal infection much as it does with rubella. Unlike CMV, maternal immunity protects against intrauterine transmission of the parasite.
As with the other infections discussed here, congenital toxoplasmosis is usually subclinical; only ten percent or so of infected newborns have clinically evident disease [17] . Two forms of the disease have been described: a neurologically dominant variety, which is the most common form, and a disseminated variety with multiple organ system involvement. Essentially, acute disease in the newborn resembles that described above for CMV. There is a greater tendency for prematurity, chorioretinitis, and hydrocephalus with generalized intracranial calcifications with congenital toxoplasmosis. Indeed, these two infections almost always have to be distinguished by laboratory means. Prognosis for normal central nervous system and perceptual development is very poor with clinically evident disease in the newborn, as it is with CMV. For this reason, various forms of therapy have been advocated for congenital toxoplasmosis, but their usefulness is yet to be adequately documented [17] .
Subclinical congenital toxoplasmosis, though far less common, is more dangerous than silent congenital CMV infection. Almost all infected infants will eventually develop serious or potentially serious defects, the most common of which is chorioretinitis [18] . Chorioretinitis may be present at birth as an isolated defect which is often overlooked. More often it develops months to years after delivery and can be progressive. Visual acuity is in jeopardy in virtually all individuals with congenital toxoplasma infection. Central nervous system disease, including deteriorating intellectual development, may not become evident for many months or years following delivery. Indeed, cerebrospinal fluid abnormalities (elevated protein levels and low-grade lymphocytosis) are often observed with congenital toxoplasmosis which is otherwise subclinical. Deafness and precocious puberty can also occur as late sequelae of subclinical infection.
As with rubella, gestational age is the major determinant of intrauterine transmission and virulence of the fetal infection with toxoplasma [19] . Intrauterine transmission is inversely related to gestational age. Thus, fetal infection occurs much more frequently following maternal infection acquired from mid-gestation to term than when acquired earlier. However, virulence of the fetal infection is inversely related to gestational age. Severe fetal disease occurs almost exclusively with maternal infection acquired in the first or early second trimesters. Whether the suggested differences in the virulence among strains of toxoplasma contribute to the broad spectrum of disease seen in the infected offspring is yet to be resolved.
Hopefully, this brief discussion has focused attention on the dynamic nature of the common chronic intrauterine infection and will alert the physician to the need for long-term assessment of the associated problems. For maximal benefit to the infected child, recognition and management of the late sequelae is equally as important as treatment of acute disease in the young infant.
